Tag Archives: Prostate Cancer

Boys of Summer

Reflections: Honoring Fred Hutchinson, Manager, Cincinnati Reds

It may be the sole summer of my youth that I recall with any real clarity: the summer of ’61, that listless season after high school graduation, when Al Mosher, Bill Salzer and I spent many humid nights at Crosley Field, watching the Cincinnati Reds, under manager Fred Hutchinson, win their way to a National League pennant and a shot at the Yankees in the World Series.

The Reds, alas, would lose the Series; Al, Bill and I would choose separate life paths but not stray apart. There would be Al’s wedding, and, later, a son. There’d be clueless weekend nights with Bill over Stroh’s beer at Shipley’s, where he’d lament statistics class, and I’d talk about my work at WKRC-TV.

And then it all fell apart.

On Dec. 15, 1967, 44 years ago today, Al stepped on a “friendly” land mine in Vietnam; his widow, Sharon, called me in New York with the news, and I went down to Washington for Al’s burial at Arlington. Bill, in the Army and stationed in Okinawa, escorted Al’s body home for the funeral. The three of us were together once more, together one final time.

I never saw Bill alive again. Two years later, a captain at Ft. Hayes, he was murdered by a soldier under his command.

Two young lives brought to an end in their mid-20s, and 40-, 50-plus years of life stolen from each, years they never had the opportunity to experience, to savor and to hold dear. I often tell myself that Bill and Al would love to be my age and have my Stage 4 prostate cancer — and that puts my cancer, and my life, in perspective; keeps my head screwed on straight; and reminds me of all the blessings of life, whatever the bumps.

Today, just to close this circle, my oncologist, besides treating me in the clinic, conducts prostate cancer research — at the Fred Hutchinson Cancer Research Center here in Seattle.

And, yes, it’s named for the manager of those Cincinnati Reds, that summer of ‘61.

The Radiation Arrow

Team SCCA: Patient with radiation therapists (L to R) Tony, Jason, Lorena

My 36 radiation treatments ended today, and we marked the occasion at Seattle Cancer Care Alliance with thank-yous, good-lucks, handshakes, a hug and a team photo of patient and therapists. In the cheer of it all, I felt the sadness of separation. I was the teammate who got traded. They stay together, and I move on. I’ll miss them.

Later, there was champagne at home (thank you, Craig). It was nothing, really, you’d call a big celebration, just a marking of the occasion with a toast and some of France’s best: one more cancer therapy, now completed.

Radiation seemed to go well — if you ignore the fact that there’s no way of knowing (yet) whether it “worked.” I asked how/when we’ll know if the radiation did me any good. The answer: When

  • I’m done with hormone suppression (in January);
  • my testosterone has returned to normal (about July);
  • and I’ve no detectable PSA,

then it worked!

Translation: not any time soon.

In fact, I hope it takes years — decades, even — to know. For the longer I go without PSA, the likelier the radiation worked its magic. I don’t know if there’s an end point where someone will announce, “It worked!” It will more likely be just three months at a time as I pinball from one PSA test to the next. We should, though, get some idea over the next few years whether my PSA, and thus my cancer, are ever to come back.

(Because I’ll be making increasingly frequent, and increasingly important, references to PSA in these posts, I’ve created a petite primer on PSA and where it fits in my health care — the PSA & Me link, above, if you’re inclined).

I do remind myself that salvage radiation was never held out to me as a slam-dunk “cure.” I knew, and I know, viscerally and intellectually, that radiation was never a solid certainty — nor was it a hollow hope. It was somewhere in the scheme of possibility, but, like whack-a-mole, the greater probability is that my cancer will pop up again.

In short, I never saw radiation as the silver bullet. It was always an uncertain arrow in the oncologic quiver.

And it has now been spent.

I shot an arrow into the air;

It fell to earth I know not where.

–Longfellow

The Writing on the Wall

The Writing on the Wall

The Writing on the Wall

I went to my first prostate cancer gathering four years ago, in Portland, Oregon, when I was fresh off surgery and unexpected news from pathology was still ringing in my ears: cancer in two lymph nodes. Entering the building, registering, and being handed my conference materials — I felt like a draftee reporting for induction into an army of conscripts.

That gathering was the 7th Annual Pacific Northwest Prostate Cancer Conference, and yesterday was the 11th, the fifth in my attendance streak. With time, I’ve come to value these get-togethers as important connections to my cancer community, as well as recurrent reminders that I am not alone. I’m always energized by my fellow cancerians, knowing the challenges and the struggles all face and seeing the strength and courage they display.

I must admit, however, that I’ve sometimes felt that much of the discussion was intended for others, not me. At the 8th conference, for example, on Sep 27, 2008, I scratched this fragment in my notebook: “Pelvic Lymph Node IMRT + Rad treat of p bed.” I just didn’t pay enough attention to take further notes of elaboration, what it all meant and why the topic was in play. It just didn’t apply to me and never would.

Today, of course, that’s exactly where my cancer journey has taken me, to that prescient scrawl — that writing on the wall — and I’m now 24 treatments into Intensity Modulated Radiation Therapy of the pelvic lymph nodes and prostate bed.

Importantly, these gatherings also provide key updates on advances in the treatment of prostate cancer. In the past 18 months, for example, there’ve been four new life-extending drugs brought to market for men with metastatic disease that’s resistant to traditional therapies. And more are on the way. What is probably next, Radium 223, is on a fast-track for approval, if all goes well, in late 2012, early 2013.

But can the track ever be fast enough when a disease causes 34,000 deaths a year?

“Why wait for tests, people gonna die in a year?” one frustrated guy asked, somewhat angrily, at the 2008 conference. He was specifically anxious for abiraterone, a drug for well advanced, metastatic prostate cancer that the FDA eventually did approve…two and one-half years later.

That man, that guy in the back row urgently hoping for help — I can only wonder whether he was still alive when hope finally became help.

This Afternoon in Cancer

Oct 17 2011 Lupron injection

Lupron: Kim, mixing it up -- and getting the lumps out

A full afternoon at the Seattle Cancer Care Alliance today: the daily radiation treatment, the weekly visit with the radiation oncologist, the quarterly check-in with my oncologist.

  • PSA test results came in at “undetectable,” which you’d largely expect, given my hormone-suppression therapy. Prior reading, in July, which was pre-hormone therapy, was 0.11. So that means PSA is down.
  • Radiation treatment #20 — check that box. I’m now solidly past the halfway point on the way to 36.
  • Another Lupron injection, which, with my Casodex pills, will keep my testosterone fully suppressed for the next three months. Upside: hot flashes in winter.
  • My oncologist said today’s Lupron shot would be the last for now. I’ll see him again in January for a quarterly check-up and a PSA test — but no more Lupron and no more Casodex after that.
  • And my radiation oncologist said he’s happy, which makes me happy, too. I reported to him that the few side effects from my salvage radiation have, so far, been mild and manageable.

And what, exactly, is salvage radiation? Bob Grindeland posed the question in his comment on my prior post, and that set me off to find an answer. I realized that while it’s a term I’ve heard, read and even used, I’d never pursued a medical definition. After all, “salvage” seemed to convey so much. Maybe even too much: say, the image of saving a ship from being battered on the rocks. But since Bob asked, here goes…

The National Cancer Institute defines salvage as “treatment that is given after the cancer has not responded to other treatments” — in my case, surgery.

The dictionary definition of salvage is more in the vernacular: “the rescue of property or material from potential loss or destruction.” Like salvaging a ship from being battered on the rocks.

Or salvaging me from cancer.

In the Rearview Mirror, Two Weeks

Shooting the radiation machine before it shoots me.

Today was treatment #10 (26 to go) — so two weeks of salvage radiation are now in the rearview mirror. All’s gone well, but…

It’s a bit early for side effects to set in, and exactly what they’ll be, how severe they’ll be and how long they’ll last — well, those are the uncertainties, all of them idiosyncratic to each one of us. However, they did caution me today to be prepared for some side effects: There’s no get-out-of-jail-free card.

Fatigue, though, is a given, but then, fatigue is cancer’s spectral companion and a hidden cost of its treatment.

I’ve now experienced one full cycle of the treatment protocol: Radiation every weekday afternoon followed by a rad onc appointment (on Mondays) and a blood draw (on Thursdays). The blood draw is for a complete blood count (CBC) to keep tabs on what the radiation to my pelvic bones may be doing to the marrow that makes blood cells. Thursday’s CBC proved to be fine.

This is a short post, just a reader-board update. The best news is: There’s no news.

An Uneventful Event

Radiation Treatment #1 (complete with red laser)

I had radiation treatment #1 today, with 35 more in queue each weekday afternoon through Nov 8. No side effects expected for the nonce.

It was easy and uneventful — well, uneventful to my eye. We’ll hope some little prostate cancer cells met an invisible and violent death, but that was nothing for me to see or even feel. The treatment itself involved radiation doses from nine different directions into a band around my pelvis. Ground zero was the prostate fossa, the area where my prostate resided until surgery.

“Lay still and breathe normally,” they told me as I lay on a hard table. The radiation machine circled my pelvis, and the therapists occasionally tweaked the positioning. Some kind of red laser beamed at me from the ceiling next to a sign that warned, Do Not Look at the Laser. All cut and dried, chop-chop. Except.

Except for the frisson, the palpable sensation I’d not had since surgery four years ago. You know how something can happen, and it just drives home and makes vivid the reality of a situation? Surgery drove home, italicized and put in bold my stark reality of 2007: I’ve got cancer, and that’s not good.

Same thing today at Radiation Oncology at the Seattle Cancer Care Alliance. I can’t remember whether today’s realization came while waiting for my first treatment or while talking to the guy waiting for his last; whether I was arranging the schedule for future treatments or was looking helplessly at the radiation machinery arrayed around me. But that old, familiar reality came back and drove itself home:

I’ve still got cancer, and that’s not good.

Surgery + 4 (and More)

Cumberland Gap, TN, KY & VA

Cumberland Gap, TN, VA & KY

It was four years ago today that I had surgery for prostate cancer, and in nine days I’ll begin “salvage” radiation for prostate cancer. Surgery, hormone therapy, now radiation. This strikes me as a lot of treatment in a relatively short period of time — and I spent more than half of the past four years on hormone therapy! All courtesy of the two tiny tumors they found in my lymph nodes after surgery.

The much-awaited phone call came Friday with the date and time to begin rad treatment at the Seattle Cancer Care Alliance. I’m thrilled to get this on the calendar at last, and I’ll be even happier to get the actual treatment underway (remind me of this when the side effects kick in).

Yes, it’s my fault we’ve put radiation off for so many months. Too many travels planned too many months ago, but all the doctors were comfortable with the delay. I’m cutting it close, though: We’ll get back to Seattle on a Monday afternoon, and I’ll report for radiation duty at 9:00 the next morning (Sep 20).

My cancer is microscopic for now and shows up on no scans. So I just have to hope that it resides precisely where the radiation will hit, but there’s no guarantee of that.

As we say all too often in the cancer journey: It is what it is.

Cancer Park

Sri Lanka Aug 2011

Sri Lanka, Aug 2011 (Photo by Rebecca Curry)

Truth be told, my prostate cancer journey has thus far been a relative walk in the park compared to the medically invasive and dramatic, life-altering experiences of others. In the time since my diagnosis, the most disruptive event has been surgery, my radical prostatectomy, and that was only two nights in the hospital, plus recovery.

Contrast that with my friend Toby, who was diagnosed in March with Mantle Cell lymphoma and whose life was abruptly up-ended. He’ll undergo his sixth (and final) R-CHOP 21 chemo treatment today — and that’s just a prelude to his stem cell transplant later this month.

So while they’ve been busy poisoning Toby this summer, I’ve been off traveling in Peru and Sri Lanka, living life much as it was before my diagnosis. (Heck, I was traveling when I received my diagnosis!) Oh, Peru and Sri Lanka brought some unintended weight loss and hot flashes from hormone-therapy, but, as I say, a relative walk in Cancer Park.

That’s about to change with my impending “salvage” radiation. My radiation oncologist is now working on the specific treatment plan — the nitty-gritty to maximize the radiation dosage to offending tissue and minimize collateral damage to the healthy. Sometime in the coming days, a phone call will come with my start date for treatment: then five days a week for seven weeks.

I’m ready — even more than ready. I have my Calypso transponders in place, and on Aug 24, I completed the remaining preliminaries: three tattoos to assist in the targeting of the radiation; a custom-made leg cradle to hold me in place; simulation scans for aiming the radiation, and the official signing of the consent form. All I need now is that telephone call.

Radiation will be my third cancer therapy in four years, not counting the experimental drug I took as part of a clinical trial, and not counting the hormone therapy and the chemo med I’m currently on (both are part of the radiation protocol). But there’ll be no more radiation after this — they just don’t do it twice. There are no do-overs, no mulligans.

It either eliminates the remaining prostate cancer in me, or it doesn’t.